Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 269

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy

JALVING, M., KOORNSTRA, J. J., WESSELING, J., BOEZEN, H. M., DE JONG, S., KLEIBEUKER, J. H.·2006·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: It is controversial whether proton pump inhibitor use leads to fundic gland polyp development. Aim: To determine whether fundic gland polyp development is due to proton pump inhibitor use and to investigate mechanisms involved. Methods: Proton pump inhibitor use and the presence of fundic gland polyps were assessed in consecutive patients undergoing oesophagogastroduodenoscopy. Biopsies from fundic gland polyps and gastric mucosa were taken. Dysplasia was graded as negative, low or high grade. Prevalence of parietal cell hyperplasia and parietal cell protrusions and the proportional cystic area were assessed. Results: 599 patients participated, 322 used proton pump inhibitors, 107 had fundic gland polyps. Long‐term proton pump inhibitor use was associated with an increased risk of fundic gland polyps (1–4.9 years use: OR 2.2, 95% CI: 1.3–3.8; ≥5 years: OR 3.8, 95% CI: 2.2–6.7) while short‐term therapy (<1 year) was not (OR 1.0, 95% CI: 0.5–1.8). Low‐grade dysplasia was found in one fundic gland polyp. Fundic gland polyps associated with long‐term proton pump inhibitor use had a larger proportional cystic area and higher frequency of parietal cell hyperplasia and parietal cell protrusion. Conclusions: Long‐term proton pump inhibitor use is associated with an up to fourfold increase in the risk of fundic gland polyps. Risk of dysplasia is negligible. Aetiologically, these polyps seem to arise because of parietal cell hyperplasia and parietal cell protrusions resulting from acid suppression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2006.03127.x

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 269

Metadata

Authors
JALVING, M., KOORNSTRA, J. J., WESSELING, J., BOEZEN, H. M., DE JONG, S., & KLEIBEUKER, J. H.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2006-10-16
Volume
24
Issue
9
Pages
1341-1348
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2095899968
Cited by
269
References
24
FWCI
11.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.03127.x
The paper
JALVING, M., KOORNSTRA, J. J., WESSELING, J., BOEZEN, H. M., DE JONG, S., & KLEIBEUKER, J. H. (2006). Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.03127.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.